Share this article
Share this article
RALEIGH, N.C., Feb. 18, 2021 /PRNewswire/ Diveplane, the company keeping humanity in artificial intelligence (AI), and BREATHE, the Health Data Research Hub for Respiratory Health in the United Kingdom, announced today that they have entered into a new partnership. As a Supporting Partner, Diveplane will support BREATHE as they seek to improve and broaden the use of health data and electronic health records in respiratory research and innovation.
Diveplane has developed several innovative AI solutions to tackle problems across a range of industries, including healthcare. GEMINAI, Diveplane s flagship product, uses patented techniques to create synthetic datasets featuring entirely new data points from existing data. These new datasets maintain the statistical properties of the original without revealing any personally identifiable information, allowing the data to be shared widely while adhering to privacy regulations and protecting person
Erecting steel structures is a hazardous occupation and a staggering 60 per cent of construction accidents can be attributed to workers being injured by rebar.
Rebar is made from different grades of steel and, as its name suggests, is used to reinforce the tensile strength of concrete structures. It is supplied in the form of rods and is fabricated into cage structures by hand before being encased in concrete to carry out its vital, unseen function.
Workers stooping to tie rebar at intersections can develop musculoskeletal disorders and a Labour Force Survey (LFS) from 2018/19 estimated 42,000 work-related cases of such injury, accumulating to three fifths of all ill health in this sector.
A UNIVERSITY is set to work on a £10m research project exploring new ways to diagnose lung cancer. The Universities of both Southampton and Leeds have come together with healthcare, diagnostics and informatics companies to test the best way of detecting cancers at a stage when they can still be cured, linking to the NHS England Targeted Lung Health Checks programme. The project, called iDx-LUNG, is part of the Government’s Early Diagnosis Mission to diagnose three-quarters of cancers at an early stage by 2028. Work is able to proceed thanks to approximately £3.5m worth of funding from UK Research and Innovation’s Industrial Strategy Challenge Fund (ISCF), part of a total investment of £10 million in the programme overall.
Major Research At Southampton To Detect Lung Cancer Earlier
Southampton University and Leeds University have collaborated with major companies to find a way of detecting lung cancers at an early enough stage to cure them.
Companies such as Johnson & Johnson, Roche, Oncimmune, Inivata, BC Platforms, and others are working with the universities after £3.5m worth of funding was made available from the UK Research and Innovation’s Industrial Strategy Challenge Fund, which will help the government’s Early Diagnosis Mission.
The Early Diagnosis Mission is an ambition to diagnose three-quarters of cancers at an early stage by 2028.
Professor Peter Johnson, Professor of Medical Oncology at the University of Southampton, who is leading the project, told the University:
NHS TRUST INTRODUCES TRANSLATION TECH
Kettering General Hospital NHS FT has begun using a live translation service within its video consultation platform to improve accessibility for non-English-speaking patients.
The move will also allow the trust to make up to 90% cost-savings on traditional translation services.
The trust deployed the eClinic video consultation platform from the patient communications provider, Healthcare Communications, in August 2020 to reduce the number of patients visiting the hospital during the pandemic.
The platform integrates with the trust’s patient administration system (PAS) and enables patients to attend appointments remotely on a browser, using a smartphone, laptop or tablet.